Shinichiro Matsuyama

Shinichiro Matsuyama

Auto-generated profile, based on publicly available information

Shinichiro Matsuyama

Department of Neurosurgery, Yokohama City University, Graduate School of Medicine, Yokohama, Japan

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
18 October 2023 in Clinical Cancer Research
Verified
Journal Article
Closed access
PDF file
THTakahiro Hayashi
Takahiro Hayashi
KTKensuke Tateishi
Kensuke Tateishi
SMShinichiro Matsuyama
Shinichiro Matsuyama
HIHiromichi Iwashita
Hiromichi Iwashita
YMYohei Miyake
Yohei Miyake
TYTetsuya Yamamoto
Tetsuya Yamamoto
Purpose: The 2021 World Health Organization (WHO) classification of central nervous system (CNS) tumors uses an integrated approach involving histopathology and molecular profiling. Because majority of adult malignant brain tumors are gliomas and primary CNS lymphomas (PCNSL), rapid differentiation of these diseases is required for therapeutic decisions. In addition, diffuse gliomas require molecular information on single-nucleotide variants (SNV), such as IDH1/2. Here, we report an intraoperative integrated diagnostic (i-ID) system to classify CNS malignant tumors, which updates legacy frozen-section (FS) diagnosis through incorporation of a qPCR-based genotyping assay. Experimental Design: FS evaluation, including GFAP and CD20 rapid IHC, was performed on adult malignant CNS tumors. PCNSL was diagnosed through positive CD20 and negative GFAP immunostaining. For suspected glioma, genotyping for IDH1/2, TERT SNV, and CDKN2A copy-number alteration was routinely performed, whereas H3F3A and BRAF SNV were assessed for selected cases. i-ID was determined on the basis of the 2021 WHO classification and compared with the permanent integrated diagnosis (p-ID) to assess its reliability. Results: After retrospectively analyzing 153 cases, 101 cases were prospectively examined using the i-ID system. Assessment of IDH1/2, TERT, H3F3AK27M, BRAFV600E, and CDKN2A alterations with i-ID and permanent genomic analysis was concordant in 100%, 100%, 100%, 100%, and 96.4%, respectively. Combination with FS and intraoperative genotyping assay improved diagnostic accuracy in gliomas. Overall, i-ID matched with p-ID in 80/82 (97.6%) patients with glioma and 18/19 (94.7%) with PCNSL. Conclusions: The i-ID system provides reliable integrated diagnosis of adult malignant CNS tumors.

5 January 2024
Verified
Other
Open access
THTakahiro Hayashi
Takahiro Hayashi
KTKensuke Tateishi
Kensuke Tateishi
SMShinichiro Matsuyama
Shinichiro Matsuyama
HIHiromichi Iwashita
Hiromichi Iwashita
YMYohei Miyake
Yohei Miyake
TYTetsuya Yamamoto
Tetsuya Yamamoto
Summary of intraoperative integrated diagnosis (i-ID) and permanent integrated diagnosis (p-ID) for retrospective cohort (153 cases)

5 January 2024
Verified
Other
Open access
PDF file
THTakahiro Hayashi
Takahiro Hayashi
KTKensuke Tateishi
Kensuke Tateishi
SMShinichiro Matsuyama
Shinichiro Matsuyama
HIHiromichi Iwashita
Hiromichi Iwashita
YMYohei Miyake
Yohei Miyake
TYTetsuya Yamamoto
Tetsuya Yamamoto
Illustrative cases in the retrospective cohort

5 January 2024
Verified
Other
Open access
PDF file
THTakahiro Hayashi
Takahiro Hayashi
KTKensuke Tateishi
Kensuke Tateishi
SMShinichiro Matsuyama
Shinichiro Matsuyama
HIHiromichi Iwashita
Hiromichi Iwashita
YMYohei Miyake
Yohei Miyake
TYTetsuya Yamamoto
Tetsuya Yamamoto
Mismatch ratio of genomic alterations in the prospective cohort

5 January 2024
Verified
Other
Open access
THTakahiro Hayashi
Takahiro Hayashi
KTKensuke Tateishi
Kensuke Tateishi
SMShinichiro Matsuyama
Shinichiro Matsuyama
HIHiromichi Iwashita
Hiromichi Iwashita
YMYohei Miyake
Yohei Miyake
TYTetsuya Yamamoto
Tetsuya Yamamoto
Illustrative mismatch cases in the prospective cohort

5 January 2024
Verified
Other
Open access
PDF file
THTakahiro Hayashi
Takahiro Hayashi
KTKensuke Tateishi
Kensuke Tateishi
SMShinichiro Matsuyama
Shinichiro Matsuyama
HIHiromichi Iwashita
Hiromichi Iwashita
YMYohei Miyake
Yohei Miyake
TYTetsuya Yamamoto
Tetsuya Yamamoto
Summary of the retrospective cohort